Screening for Urinary Incontinence by Primary Care Providers

Urinary Incontinence Clinical Trial

Official title:

Screening for Urinary Incontinence by Primary Care Providers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00178334
• Other study ID #: 11355
• Status: Completed
• Phase: N/A
• First received: September 12, 2005
• Last updated: January 28, 2013
• Start date: March 2006
• Est. completion date: July 2006

Study information

• Verified date: January 2013
• Source: University of Rochester
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Food and Drug Administration
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to:

• Assess the rate of screening for urinary incontinence (UI) in women by their primary care providers

• Identify the type of screening used by primary care providers

• Identify barriers to screening for UI

• Identify differences in screening rates between specialties

• Assess whether primary care providers view UI as a serious medical problem

• Assess the comfort level of primary care providers in the diagnosis and treatment of UI

• Identify primary care providers' preferred mode of learning more about UI

Description:

UI is a very common condition whose prevalence can be expected to increase dramatically in the coming decades. Treatment options are available to improve women's health and quality of life. However, inadequate communication between physicians and patients leads to decreased diagnosis and treatment. Past studies evaluating the use of screening by primary care providers, who act as gatekeepers in our healthcare system, clearly demonstrate that improvements must be made in the screening system. We propose a survey of local primary care providers to quantify screening rates for UI and identify barriers to successful screening. The information collected in this survey will allow us to identify methods such as targeted education opportunities and patient literature or questionnaires that will assist providers and their patients in initiating discussion and evaluation of UI.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 554
• Est. completion date: July 2006
• Est. primary completion date: July 2006
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 21 Years and older

Eligibility

Inclusion Criteria:

• All primary care providers in the Greater Rochester metropolitan area, including:

Primary care Medical Doctors (MD), Doctors of Osteopathy (DO), Primary care Nurse Practitioners (NP), and Physician Assistants (PA)

Exclusion Criteria:

• Physicians in the Greater Rochester metropolitan area who are not primary care providers

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Urinary Incontinence

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
University of Rochester	Pfizer

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Questionnaire		Response to mailing	No